Genenta signs binding offer to acquire Sophia High Tech for EUR 6 million Mar 27, 2026 05:42AM
Genenta Science explores biotech platform partnerships amid company transformation Mar 24, 2026 04:18AM
Genenta Science CEO owns 10% stake through market purchases Dec 19, 2025 05:13AM
Genenta Science reports survival data from brain tumor trial Nov 24, 2025 05:32AM
H.C. Wainwright Reiterates Buy Rating on Genenta Science S.p.A. (GNTA) Jul 2, 2025 06:40AM


May 8, 2025 07:00AM Genenta Science, SpA Announces Participation in the D. Boral Capital Inaugural Global Conference
Mar 19, 2025 09:29AM Genenta Science (GNTA) Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates
Oct 3, 2024 06:59AM H.C. Wainwright Reiterates Buy Rating on Genenta Science S.p.A. (GNTA)
Oct 2, 2024 06:30AM Genenta Science (GNTA) Secures Approval for Trial for Metastatic Renal Cell Cancer